|
|
 |
|
Viewing report
|
|
|
|
Computer Techniques in Preclinical and Clinical Drug Development
Informa Healthcare, July 1996, Pages: 256
It is estimated that 80 to 90% of drugs under development never make it to the marketplace due to insufficient clinical activity, unacceptable toxicity, rapid appearance of drug resistance, or other factors that should be, at least partially, predictable from preclinical testing. This new text asks the question, 'How can we use computational methods to improve the success rate in drug development?' Computer Techniques in Preclinical and Clinical Drug Development shows how modeling makes it possible to extract the maximum amount of information and predictive value from preclinical data. Computer modeling methods from the areas of pharmacokinetics, pharmacodynamics, cytokinetics, and inhibition kinetics of multi-enzyme pathways are all discussed in this unique reference source.
Customers who bought this item also bought
Preclinical Drug Development, Second Edition
Antimicrobial Pharmacodynamics in Theory and Clinical Practice, Second Edition
Advances in Imaging Biomarkers: Innovative Technologies, Applications in R&D and Clinical Practice, and Informatics and Regulatory Requirements
Drug Stereochemistry: Analytical Methods and Pharmacology
Drug Stereochemistry: Analytical Methods and Pharmacology, Third Edition
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success
The Future of Metabolomics: Building Competitive Advantage in Drug Discovery, Clinical Development and Diagnostics
Toxicity Screening 2009
The Executive Guide to Molecular Imaging
Comprehensive Toxicology. Edition No. 2
|
|
|
|
